CAS: 1009119-83-8 - 1H-Imidazole,5,5'-[1,1'-biphenyl]-4,4'-​diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4)

Formula: C₂₆H₂₈N₆.4ClH

InChI: InChI=1S/C26H28N6.4ClH/c1-3-21(27-13-1)25-29-15-23(31-25)19-9-5-17(6-10-19)18-7-11-20(12-8-18)24-16-30-26(32-24)22-4-2-14-28-22;;;;/h5-12,15-16,21-22,27-28H,1-4,13-14H2,(H,29,31)(H,30,32);4*1H/t21-,22-;;;;/m0..../s1

InChI key: InChIKey=AYOXSBJGFNPGNK-VDUNKYASSA-N

SMILES: Cl.N=1C=C(NC1C2NCCC2)C=3C=CC(=CC3)C=4C=CC(=CC4)C5=CN=C(N5)C6NCCC6

Synonyms:

• 5,5'-[1,1'-Biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole] hydrochloride
• Daclatasvir intermediate-5

HCV-IN-29

CAS: 1009119-83-8

HCV-IN-29 is a hepatitis C virus (HCV) inhibitor.

• Formula: C₂₆H₃₂Cl₄N₆
• Purity: 99.66%
• Color and Shape: Solid
• Molecular weight: 570.38

1H-Imidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride (1:4)

CAS: 1009119-83-8

• Formula: C₂₆H₃₂Cl₄N₆
• Purity: 97%
• Color and Shape: Solid
• Molecular weight: 570.3845

Daclatasvir Impurity 10 TetraHCl

CAS: 1009119-83-8

• Formula: C₂₆H₂₈N₆HCl
• Color and Shape: Pale Yellow Solid
• Molecular weight: 424.55 4*36.46

1H-Imidazole, 5,5’-[1,1’-biphenyl]-4,4’-diylbis[2-(2S)-2-pyrrolidinyl-, hydrochloride

CAS: 1009119-83-8

Intermediate in the synthesis of daclatasvir

• Formula: C₂₆H₂₉ClN₆
• Purity: Min. 95%
• Molecular weight: 461 g/mol